[1]
“INTERLEUKIN-40 AS A PREDICTIVE TOOL OF RESPONSE TO TREATMENT FOR INSULIN RESISTANCE IN PATIENTS WITH TYPE 2 DIABETES”, CMN, vol. 6, no. 2, pp. 3635–3642, Aug. 2024, Accessed: Aug. 22, 2025. [Online]. Available: http://cahiersmagellanes.com/index.php/CMN/article/view/633